GlassScriptPhysician profile
David Charles Willis
NPI 1235261371
$490.11
in general payments reported to CMS, 2019-2025
13 companies · $20.16 in 2025
The $20.16 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $37.32 · 2021: $32.09 · 2022: $58.36 · 2023: $45.79 · 2024: $89.16 · 2025: $20.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $90.05 | 2019-2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $55.73 | 2023-2024 | Spravato, Invega Sustenna |
| Merck Sharp & Dohme LLC | $49.15 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.32 | 2019 | |
| Pfizer INC. | $34.18 | 2019-2024 | |
| Novo Nordisk INC | $33.69 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $31.84 | 2019-2020 | |
| Neos Therapeutics, LP | $31.42 | 2019-2021 | |
| Stryker Corporation | $21.59 | 2023 | Mako |
| Aytu Biopharma, INC. | $18.62 | 2024 | Karbinal |
| Horizon Therapeutics Plc | $16.33 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.